BRCA1 and breast carcinoma: Based on the data of whole-exome sequencing of the nine cases, we further screened the potential gene in an additional 439 unrelated familial breast cancer patients without BRCA1/2 mutations and performed in vitro functional analyses to evaluate whether the mutations disrupt the function of the potential gene.